tripeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-10-28. Numbers and descriptions here follow the published literature rather than marketing material.
Glutathione is a tripeptide composed of glutamate, cysteine, and glycine, and it is the most abundant non-protein thiol in most living cells. The reduced form, GSH, carries a sulfhydryl group that can donate electrons, while the oxidized form, GSSG, forms when two GSH molecules link via a disulfide bond. The balance between these two forms helps define the cellular redox environment, and their ratio is often used as an indicator of oxidative stress. Because the sulfhydryl group is reactive, glutathione participates in many cellular processes, including detoxification and protein regulation.
Glutathione is synthesized in two ATP-dependent steps. First, gamma-glutamylcysteine synthetase links glutamate and cysteine; second, glutathione synthetase adds glycine to form the complete tripeptide. The pathway is feedback-inhibited by GSH itself, which helps maintain steady intracellular levels. Tissues vary widely in glutathione content, with the liver typically containing the highest concentrations, followed by the kidneys, lungs, and erythrocytes. Because cysteine is often limiting, its availability influences synthesis rates, and regulation of this pathway varies by cell type.
Glutathione serves as a cofactor for several enzymes, including glutathione peroxidase and glutathione S-transferase. These enzymes help reduce hydrogen peroxide and lipid peroxides, and they conjugate reactive electrophiles for excretion. The molecule also acts as a reservoir for cysteine, an amino acid that is prone to oxidation. In addition, glutathione participates in the metabolism of nitric oxide, leukotrienes, and prostaglandins. Its roles extend to cell signaling, apoptosis, and the regulation of protein function through S-glutathionylation.
Glutathione is a small tripeptide built from glutamic acid, cysteine, and glycine. Its peptide bond between glutamate and cysteine involves the gamma-carboxyl group rather than the usual alpha-carboxyl group. This structure gives the molecule a reactive thiol on the cysteine residue. The reduced form, often abbreviated GSH, is the predominant intracellular species in many cell types. Because the thiol can donate electrons, glutathione participates in redox chemistry and in the conjugation of reactive molecules.
Cells synthesize glutathione through two ATP-dependent steps: glutamate-cysteine ligase joins glutamate and cysteine, and glutathione synthetase adds glycine to form the complete tripeptide. Breakdown occurs through gamma-glutamyl transpeptidase and subsequent peptidase reactions, forming the gamma-glutamyl cycle. Within cells, glutathione also forms a disulfide-linked dimer called GSSG when two GSH molecules react. The balance between GSH and GSSG is widely used as an indicator of oxidative conditions, although the ratio can vary by compartment and tissue.
Glutathione supports several cellular processes beyond direct antioxidant action. It serves as a cofactor for glutathione peroxidase and glutathione S-transferase enzymes, which reduce peroxides and conjugate electrophiles, respectively. The molecule also acts as a reservoir of cysteine, an amino acid that can limit protein synthesis and redox signaling. In human nutrition, oral glutathione is sold as a supplement, but how much intact glutathione reaches tissues after ingestion remains an active research question. Clinical claims about supplementation are not uniformly supported by controlled trials.
| Property | Value | Notes |
|---|---|---|
| Chemical formula | C10H17N3O6S | Reduced form (GSH) |
| Molar mass | 307.32 g/mol | For GSH; GSSG is 612.63 g/mol |
| Appearance | White crystalline powder | Usually lyophilized |
| Solubility in water | Freely soluble (≥100 mg/mL) | pH dependent |
| Typical storage | -20 °C, desiccated | Protect from light and oxygen |
Several techniques are used for quantification. Enzymatic recycling assays rely on glutathione reductase and a colorimetric or fluorescent readout, offering sensitivity for total glutathione. High-performance liquid chromatography can separate GSH from GSSG and other thiols, often with UV, fluorescence, or electrochemical detection. Mass spectrometry provides structural confirmation and can quantify low-abundance species when paired with separation. Each approach has trade-offs in specificity, throughput, and equipment requirements, so method selection depends on the research question and available instrumentation.
Stability depends on pH, temperature, oxygen exposure, and trace metals. Aqueous solutions of reduced glutathione are susceptible to oxidation, especially when neutral or alkaline and exposed to air. Transition metal ions can catalyze thiol oxidation, so chelators and inert atmospheres are sometimes used in research settings. Standards are typically stored cold and desiccated, with limited freeze-thaw cycles. Questions remain about how closely in vitro stability data reflect the behavior of glutathione within intact cells and tissues.
Glutathione is a tripeptide composed of glutamate, cysteine, and glycine. Its glutamate-cysteine linkage uses the gamma-carboxyl group of glutamate, a feature that resists standard peptidases. The cysteine residue provides a thiol group, which gives the molecule its reducing character. In cells, glutathione is often the most abundant small-molecule thiol, with concentrations varying widely by tissue and compartment. It exists mainly in a reduced form called GSH, while oxidation produces a disulfide-linked dimer called GSSG.
Biosynthesis proceeds in two ATP-dependent steps. First, glutamate-cysteine ligase joins glutamate and cysteine. Second, glutathione synthetase adds glycine to the intermediate. The pathway is regulated by cysteine availability, enzyme expression, and feedback inhibition by glutathione itself. Liver tissue has a particularly high capacity for synthesis and export. Because the molecule is made inside cells, circulating glutathione reflects a balance of release, uptake, and breakdown rather than simple dietary supply.
Functionally, glutathione supports redox balance by donating electrons and becoming oxidized. It also serves as a cofactor for enzymes such as glutathione peroxidases and glutathione S-transferases. These enzymes participate in peroxide reduction and in conjugation reactions that help process reactive molecules. Separate from antioxidant roles, glutathione can modify protein cysteines through S-glutathionylation, influencing enzyme activity and signaling. Research continues to examine how these chemical roles translate into whole-organism effects.
The 4n+2 chain of uranium-238 is called the "uranium series" or "radium series", the latter from the first member known when it was named, radium-226. The series terminates with lead-206, 8 alpha decays and 6 beta decays from uranium. The total energy released from uranium-238 to lead-206, including the energy lost to neutrinos, is 51.69 MeV; from californium-250, 68.28 MeV.
=== Intracellular receptors === Intracellular receptors exist freely in the cytoplasm, nucleus, or can be bound to organelles or membranes. For example, the presence of nuclear and mitochondrial receptors is well documented. The binding of a ligand to the intracellular receptor typically induces a response in the cell. Intracellular receptors often have a level of specificity, this allows the receptors to initiate certain responses when bound to a corresponding ligand. Intracellular receptors typically act on lipid soluble molecules. The receptors bind to a group of DNA binding proteins. Upon binding, the receptor-ligand complex translocates to the nucleus where they can alter patterns of gene expression. Steroid hormone receptors are found in the nucleus, cytosol, and also on the plasma membrane of target cells. They are generally intracellular receptors (typically cytoplasmic or nuclear) and initiate signal transduction for steroid hormones which lead to changes in gene expression over a time period of hours to days. The best studied steroid hormone receptors are members of the nuclear receptor subfamily 3 (NR3) that include receptors for estrogen (group NR3A) and 3-ketosteroids (group NR3C). In addition to nuclear receptors, several G protein-coupled receptors and ion channels act as cell surface receptors for certain steroid hormones.
Dean Paul Martin became a tennis player, actor and a captain in the California Air National Guard. He was married to actress Olivia Hussey and figure skater Dorothy Hamill, and was killed while piloting an F-4 Phantom jet in 1987. In 1996, Sundazed Music released The Rebel Kind: The Best of Dino, Desi & Billy, in which all of the group's singles and other non-cover material was collected for the first time on one album. From 1998 to 2010, a reconfiguration of the group, known as "Ricci, Desi, & Billy", performed at various times, in addition to releasing two live albums. The band performed new material and the original hits, with Ricci Martin, the youngest son of singer Dean Martin, replacing his late older brother, Dean Paul Martin. Billy Hinsche died of lung cancer on November 20, 2021, after a short illness. His mother, Celia Hinsche, also died on the same day.
Sources: en.wikipedia.org
=== MeSH D12.644.548 – peptide hormones === MeSH D12.644.548.009 – activins MeSH D12.644.548.009.500 – inhibin-beta subunits MeSH D12.644.548.014 – adiponectin MeSH D12.644.548.020 – atrial natriuretic factor MeSH D12.644.548.100 – bombesin MeSH D12.644.548.150 – calcitonin MeSH D12.644.548.200 – corticotropin-releasing hormone MeSH D12.644.548.275 – gastric inhibitory polypeptide MeSH D12.644.548.280 – gastrins MeSH D12.644.548.343 – glucagon precursors MeSH D12.644.548.343.249 – enteroglucagons MeSH D12.644.548.343.249.500 – glucagon-like peptide 1 MeSH D12.644.548.343.500 – glucagon MeSH D12.644.548.387 – inhibins MeSH D12.644.548.387.500 – inhibin-beta subunits MeSH D12.644.548.393 – insulin MeSH D12.644.548.393.408 – insulin, isophane MeSH D12.644.548.393.532 – insulin, long-acting MeSH D12.644.548.393.788 – proinsulin MeSH D12.644.548.393.788.250 – c-peptide MeSH D12.644.548.400 – leptin MeSH D12.644.548.500 – motilin MeSH D12.644.548.560 – msh release-inhibiting hormone MeSH D12.644.548.580 – msh-releasing hormone MeSH D12.644.548.585 – natriuretic peptide, c-type MeSH D12.644.548.587 – pancreatic polypeptide MeSH D12.644.548.588 – parathyroid hormone-related protein MeSH D12.644.548.590 – parathyroid hormone MeSH D12.644.548.590.850 – teriparatide MeSH D12.644.548.592 – peptide phi MeSH D12.644.548.595 – peptide yy MeSH D12.644.548.600 – pituitary hormone release inhibiting hormones MeSH D12.644.548.620 – pituitary hormone-releasing hormones MeSH D12.644.548.691 – pituitary hormones MeSH D12.644.548.691.525 – pituitary hormones, anterior MeSH D12.644.548.691.525.343 – gonadotropins, pituitary MeSH D12.644.548.691.525.343.288 – follicle stimulating hormone MeSH D12.644.548.691.525.343.288.500 – follicle stimulating hormone, beta subunit MeSH D12.644.548.691.525.343.288.750 – glycoprotein hormones, alpha subunit MeSH D12.644.548.691.525.343.463 – luteinizing hormone MeSH D12.644.548.691.525.343.463.249 – glycoprotein hormones, alpha subunit MeSH D12.644.548.691.525.343.463.500 – luteinizing hormone, beta subunit MeSH D12.644.548.691.525.343.583 – menotropins MeSH D12.644.548.691.525.343.583.500 – urofollitropin MeSH D12.644.548.691.525.425 – growth hormone MeSH D12.644.548.691.525.425.875 – human growth hormone MeSH D12.644.548.691.525.525 – prolactin MeSH D12.644.548.691.525.690 – pro-opiomelanocortin MeSH D12.644.548.691.525.690.130 – corticotropin MeSH D12.644.548.691.525.690.130.050 – alpha-msh MeSH D12.644.548.691.525.690.130.200 – cosyntropin MeSH D12.644.548.691.525.690.480 – lipotropin MeSH D12.644.548.691.525.690.583 – melanocyte-stimulating hormones MeSH D12.644.548.691.525.690.583.050 – alpha-msh MeSH D12.644.548.691.525.690.583.075 – beta-msh MeSH D12.644.548.691.525.690.583.115 – gamma-msh MeSH D12.644.548.691.525.883 – thyrotropin MeSH D12.644.548.691.525.883.249 – glycoprotein hormones, alpha subunit MeSH D12.644.548.691.525.883.500 – thyrotropin, beta subunit MeSH D12.644.548.691.692 – pituitary hormones, posterior MeSH D12.644.548.691.692.433 – oxytocin MeSH D12.644.548.691.692.781 – vasopressins MeSH D12.644.548.691.692.781.100 – argipressin MeSH D12.644.548.691.692.781.100.250 – deamino arginine vasopressin MeSH D12.644.548.691.692.781.400 – lypressin MeSH D12.644.548.691.692.781.400.350 – felypressin MeSH D12.644.548.691.692.781.700 – ornipressin MeSH D12.644.548.691.692.881 – vasotocin MeSH D12.644.548.726 – placental hormones MeSH D12.644.548.726.367 – chorionic gonadotropin MeSH D12.644.548.726.367.125 – chorionic gonadotropin, beta subunit, human MeSH D12.644.548.726.367.562 – glycoprotein hormones, alpha subunit MeSH D12.644.548.726.451 – gonadotropins, equine MeSH D12.644.548.726.692 – placental lactogen MeSH D12.644.548.762 – relaxin MeSH D12.644.548.786 – resistin MeSH D12.644.548.810 – secretin MeSH D12.644.548.857 – somatostatin MeSH D12.644.548.869 – thymosin MeSH D12.644.548.905 – urotensins MeSH D12.644.548.952 – vasoactive intestinal peptide
=== Worm infections === For river blindness (onchocerciasis) and lymphatic filariasis, ivermectin is typically given as part of mass drug administration campaigns that distribute the drug to all members of a community affected by the disease. Adult worms survive in the skin and eventually recover to produce larval worms again; to keep the worms at bay, ivermectin is given at least once per year for the 10–15-year lifespan of the adult worms. The World Health Organization (WHO) considers ivermectin the drug of choice for strongyloidiasis. Ivermectin is also the primary treatment for Mansonella ozzardi and cutaneous larva migrans. The US Centers for Disease Control and Prevention (CDC) recommends ivermectin, albendazole, or mebendazole as treatments for ascariasis. Ivermectin is sometimes added to albendazole or mebendazole for whipworm treatment, and is considered a second-line treatment for gnathostomiasis. When co-administered, ivermectin and albendazole act in synergy. Ivermectin targets the parasite's nervous and muscular systems, causing paralysis, while albendazole disrupts the parasite's metabolism and energy production. This dual approach immobilizes and kills the parasite and improves the treatment's effectiveness. In January 2025, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive scientific opinion for ivermectin/albendazole for the treatment of infections caused by several types of worm parasites including lymphatic filariasis, a neglected tropical disease.
=== Aortic stenosis === Symptoms of aortic stenosis may include heart failure symptoms, such as dyspnea on exertion (most frequent symptom), orthopnea and paroxysmal nocturnal dyspnea, angina pectoris, and syncope, usually exertional. Medical signs of aortic stenosis include pulsus parvus et tardus, that is, diminished and delayed carotid pulse, fourth heart sound, decreased A2 sound, sustained apex beat, precordial thrill. Auscultation may reveal a systolic murmur of a harsh crescendo-decrescendo type, heard in 2nd right intercostal space and radiating to the carotid arteries.
His4 catalyzes the oxidation of l-histidinol to form l-histidinal, an amino aldehyde. In the last step, l-histidinal is converted to l-histidine. The histidine biosynthesis pathway has been studied in the fungus Neurospora crassa, and a gene (His-3) encoding a multienzyme complex was found that was similar to the His4 gene of the bacterium E. coli. A genetic study of N. crassa histidine mutants indicated that the individual activities of the multienzyme complex occur in discrete, contiguous sections of the His-3 genetic map, suggesting that the different activities of the multienzyme complex are encoded separately from each other. However, mutants were also found that lacked all three activities simultaneously, suggesting that some mutations cause loss of function of the complex as a whole. Like animals and microorganisms, plants need histidine for their growth and development. But unlike animals, microorganisms and plants can synthesize histidine. Both synthesize histidine from the biochemical intermediate phosphoribosyl pyrophosphate. In general, the histidine biosynthesis is very similar in plants and microorganisms.
Sources: en.wikipedia.org
Hitler believed that as centuries passed, his huge domed assembly hall would acquire great holy significance and become a hallowed shrine as important to National Socialism as St. Peters in Rome is to Roman Catholicism. Such cultism was at the root of the entire plan. Nevertheless, Giesler remarked that Hitler never made plans for world domination and that to suggest as much is not only nonsense (Unsinn) but 'Speer Rubbish' (Speerlicher Quatsch).
In molecular biology the MAPEG (Membrane-Associated Proteins in Eicosanoid and Glutathione metabolism) family of proteins are a group of membrane associated proteins with highly divergent functions. Included are the 5-lipoxygenase-activating protein (gene FLAP), leukotriene C4 synthase (EC 2.5.1.37), which catalyzes the production of leukotriene C4 (LTC4) from leukotriene A4 (LTA4), and microsomal glutathione S-transferase II (EC 2.5.1.18) (GST-II), which also produces LTC4 from LTA4. Another example is prostaglandin E synthase. This enzyme catalyses the synthesis of PGE2 from PGH2 (produced by cyclooxygenase from arachidonic acid). Because of structural similarities in the active sites of FLAP, LTC4 synthase, and PGE synthase, substrates for each enzyme can compete with one another and modulate synthetic activity.
== Resistance == Resistance is a major cause of treatment failure in chemotherapeutic drugs and results in cancer cell survival despite exposure to such toxins. Broadly, resistance types can be classified based on the points at which cancer cells are no longer susceptible to the effects of chemotherapeutic drugs. One form of resistance is known as primary, or natural resistance, where cancer cells possess innate mechanisms that allow them to be unresponsive to chemotherapeutic drug exposure from the very beginning of its administration. Contrarily, acquired resistance is characterized by an initial, brief period of cancer cell susceptibility to the applied chemotherapeutic agent, followed by later stages of poor drug response. Despite these differences between the points at which resistance emerges, either form can result in what is known as multi-drug resistance, essentially allowing cancer cells to evade the effects of both similarly and differently functioning chemotherapeutic drugs regardless of their previous exposure to them. There are various contributors to emerging resistance in cancer, one of which is the presence of small pumps on the surface of cancer cells that actively transport concentrations of chemotherapy drugs from inside the cell to the outside, otherwise known as efflux pumps. However, these pumps are not unique characteristics of cancer cells whereas in normal functioning cells, efflux pumps are actually engaged in life-sustaining processes that help avoid the accumulation of waste and toxin absorption in the body.
Sources: en.wikipedia.org
Glutathione is a tripeptide of three amino acids: glutamate, cysteine, and glycine. The cysteine residue provides the sulfhydryl group that gives the molecule its reducing properties.
GSH is the reduced form, which contains a free sulfhydryl group. GSSG is the oxidized form, formed when two GSH molecules join through a disulfide bond. The ratio of GSH to GSSG is often used to assess cellular redox status.
No, glutathione is synthesized endogenously in most cells. It is not classified as an essential nutrient because the body can produce it from amino acid precursors. Dietary sources exist, but they are not required to maintain life.
It is a tripeptide of glutamic acid, cysteine, and glycine. The linkage between glutamate and cysteine uses the gamma-carboxyl group, which is unusual for peptides.